Department of Cancer Immunology & Virology, Dana Farber Cancer Institute, Boston, MA 02215, USA.
Alzheimer Research Unit, MassGeneral Institute for Neurodegenerative Disease, Charlestown, MA 02129, USA.
G3 (Bethesda). 2023 Jan 12;13(1). doi: 10.1093/g3journal/jkac292.
Premature transcription termination (i.e. attenuation) is a potent gene regulatory mechanism that represses mRNA synthesis. Attenuation of RNA polymerase II is more prevalent than once appreciated, targeting 10-15% of mRNA genes in yeast through higher eukaryotes, but its significance and mechanism remain obscure. In the yeast Saccharomyces cerevisiae, polymerase II attenuation was initially shown to rely on Nrd1-Nab3-Sen1 termination, but more recently our laboratory characterized a hybrid termination pathway involving Hrp1, an RNA-binding protein in the 3'-end cleavage factor. One of the hybrid attenuation gene targets is DEF1, which encodes a repair protein that promotes degradation of polymerase II stalled at DNA lesions. In this study, we characterized the chromosomal DEF1 attenuator and the functional role of Hrp1. DEF1 attenuator mutants overexpressed Def1 mRNA and protein, exacerbated polymerase II degradation, and hindered cell growth, supporting a biologically significant DEF1 attenuator function. Using an auxin-induced Hrp1 depletion system, we identified new Hrp1-dependent attenuators in MNR2, SNG1, and RAD3 genes. An hrp1-5 mutant (L205S) known to impair binding to cleavage factor protein Rna14 also disrupted attenuation, but surprisingly no widespread defect was observed for an hrp1-1 mutant (K160E) located in the RNA-recognition motif. We designed a new RNA recognition motif mutant (hrp1-F162W) that altered a highly conserved residue and was lethal in single copy. In a heterozygous strain, hrp1-F162W exhibited dominant-negative readthrough defects at several gene attenuators. Overall, our results expand the hybrid RNA polymerase II termination pathway, confirming that Hrp1-dependent attenuation controls multiple yeast genes and may function through binding cleavage factor proteins and/or RNA.
过早转录终止(即衰减)是一种强大的基因调控机制,可抑制 mRNA 的合成。衰减 RNA 聚合酶 II 的现象比人们曾经认为的更为普遍,在从酵母到高等真核生物的过程中,它靶向了 10-15%的 mRNA 基因,但它的意义和机制仍然不清楚。在酵母酿酒酵母中,最初表明聚合酶 II 衰减依赖于 Nrd1-Nab3-Sen1 终止,但最近我们实验室描述了一种涉及 Hrp1 的杂交终止途径,Hrp1 是 3'端切割因子中的一种 RNA 结合蛋白。杂交衰减基因靶标之一是 DEF1,它编码一种修复蛋白,可促进在 DNA 损伤处停滞的聚合酶 II 的降解。在这项研究中,我们对 DEF1 衰减子和 Hrp1 的功能作用进行了特征描述。DEF1 衰减子突变体过表达 Def1 mRNA 和蛋白,加剧了聚合酶 II 的降解,并阻碍了细胞生长,支持 DEF1 衰减子具有重要的生物学功能。使用吲哚乙酸诱导的 Hrp1 耗尽系统,我们在 MNR2、SNG1 和 RAD3 基因中鉴定了新的依赖 Hrp1 的衰减子。一个已知的 hrp1-5 突变体(L205S),该突变体损害了与切割因子蛋白 Rna14 的结合,也破坏了衰减,但令人惊讶的是,位于 RNA 识别基序中的 hrp1-1 突变体(K160E)没有观察到广泛的缺陷。我们设计了一种新的 RNA 识别基序突变体(hrp1-F162W),该突变改变了一个高度保守的残基,在单拷贝时是致命的。在杂合菌株中,hrp1-F162W 在几个基因衰减子中表现出显性通读缺陷。总的来说,我们的结果扩展了杂交 RNA 聚合酶 II 终止途径,证实了依赖 Hrp1 的衰减控制了多个酵母基因,并且可能通过结合切割因子蛋白和/或 RNA 来发挥作用。